By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Antibe Therapeutics Inc. 

1063 King St. West
Suite 210
Hamilton  Ontario  L8S 4S3  Canada
Phone: 905-515-6132 Fax: 905-528-9862


SEARCH JOBS


Industry
Biotechnology






Company News
Antibe Therapeutics (ATE.V) Announces Closing Of Public Offering 8/18/2017 10:06:46 AM
Antibe Therapeutics (ATE.V) Receives Approval To Initiate Phase II Gastrointestinal Endoscopy Clinical Trial 8/2/2017 6:11:50 AM
Antibe Therapeutics (ATE.V) Reports 2017 Year-End Financial And Operating Results 7/31/2017 6:15:33 AM
Antibe Therapeutics (ATE.V) Announces Closing Of Public Offering 6/21/2017 8:09:55 AM
Antibe Therapeutics (ATE.V) Announces Filing Of Final Short Form Prospectus 6/15/2017 11:05:43 AM
Antibe Therapeutics (ATE.V) Announces Pricing Of Offering 5/26/2017 8:17:18 AM
Antibe Therapeutics (ATE.V) Announces Proposed Offering Of Units 5/25/2017 6:41:09 AM
Antibe Therapeutics (ATE.V) Engages Topstone Research And Appoints Dr Francis Chan As Key Advisor For Phase II Clinical Trial Of ATB-346 5/12/2017 6:12:41 AM
Antibe Therapeutics (ATE.V) Advances Development Of ATB-352 In Wake Of Growing Global Opioid Epidemic 4/26/2017 5:58:54 AM
Antibe Therapeutics (ATE.V) Provides Update On Clinical Development Program For Its Lead Drug, ATB-346 4/18/2017 6:11:01 AM
123456789
//-->